Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for Orelabrutinib

Release date: 2024-07-10 14:01:21     Recommended: 92

05L0971_23 奥希替尼 批文_00.jpg

Suitable for adult mantle cell lymphoma (MCL) patients who have received at least one treatment in the past. Adult chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients who have received at least one treatment in the past. Used to treat patients with relapsed/refractory marginal zone lymphoma (MZL).

Company News

Research News

Drug news